Optimalisation of the Treatment of Acute Neonatal Hyperammonaemia

Recruiting Observational Study
Hyperammonemic Encephalopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 1
Sex
Any
Study type
Observational
Participants needed
10 (estimated)
Sponsor
University Hospital, Ghent · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute neonatal hyperammonemia is associated with poor neurological outcomes and high mortality. A user-friendly and widely applicable algorithm - based on kinetics - to tailor the treatment of acute neonatal hyperammonemia. A single compartmental model was calibrated assuming a distribution volume equal to the patient's total body water (V), as calculated using Wells' formula, and dialyzer clearan…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * severe acute neonatal hyperammonaemia for which acute hemodialysis is indicated * inborn error of metabolism * below 1 year of age Exclusion Criteria: * older than 1 year
Contacts

Evelien Snauwaert, MD, PhD

00 32 9 332 69 05

evelien.snauwaert@uzgent.be

CONTACT

Sunny Eloot, PhD

00 32 9 332 10 25

sunny.eloot@ugent.be

CONTACT